Torpharm Argument Equating OTC Ranitidine With Rx Doses "Frivolous" - FDA
This article was originally published in The Tan Sheet
Executive Summary
Torpharm's position that 75 mg OTC ranitidine is the same as the 300 mg prescription drug is "frivolous," FDA maintains in a reply document filed April 19 in D.C. federal court in Apotex v. Shalala. The document supports the agency's motion to dismiss the suit. A hearing in the case is scheduled for April 29.